Aaron Morris Etra MD
Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Division of Hematology and Medical Oncology
Join to View Full Profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756
Dr. Etra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2012 - 2015
Albert Einstein College of MedicineClass of 2012- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2015 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Autologous Stem Cell Transplant for Crohn's Disease Start of enrollment: 2018 Feb 22
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD.Yu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, Ioannis E Louloudis, Paibel Aguayo-Hiraldo
Blood Advances. 2025-11-25 - 2 citationsRemestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD.Aaron Etra, James L M Ferrara, John E Levine
Blood. 2025-10-16 - Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.Ioannis Evangelos Louloudis, Yi-Bin Chen, Nikolaos Spyrou, Amin Alousi, Nikolaos Katsivelos
Transplantation and Cellular Therapy. 2025-09-25
Press Mentions
Itacitinib Appears Effective for Acute Graft-Versus-Host DiseaseFebruary 12th, 2023- Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow TransplantDecember 13th, 2022
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
